Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Prudential Financial Inc. Has $4.41 Million Holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX)
09:48am, Tuesday, 17'th Mar 2020
Prudential Financial Inc. lessened its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange
Amneal Pharmaceuticals Inc (NYSE:AMRX) Given Consensus Rating of "Hold" by Brokerages
06:04am, Saturday, 14'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) has received an average recommendation of “Hold” from the thirteen analysts that are currently covering the stock, Marketbeat reports. Two analysts have rate
Chintu Patel Buys 100,000 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) Stock
09:58am, Friday, 13'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chintu Patel acquired 100,000 shares of the business’s stock in a transaction dated Tuesday, March 10th. The shares were bought at an average price of $3.0
Insider Buying: Amneal Pharmaceuticals Inc (NYSE:AMRX) Director Acquires 32,111 Shares of Stock
11:42am, Thursday, 12'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) Director Gautam Patel bought 32,111 shares of Amneal Pharmaceuticals stock in a transaction on Monday, March 2nd. The stock was acquired at an average cost of $3
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte
Chirag K. Patel Purchases 34,641 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) Stock
10:24am, Thursday, 12'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chirag K. Patel bought 34,641 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was purchased at an average cost of $3.87 per
BRIEF-Amneal Pharmaceuticals Appoints Tasos Konidaris As Senior Vice President, CFO
09:36pm, Wednesday, 11'th Mar 2020
Amneal Pharmaceuticals Inc:
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
09:36pm, Wednesday, 11'th Mar 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has appointed Tasos Konidaris as Senior Vice President, Chief Financial Officer, effective March 12, 2020. Mr.
Insider Buying: Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Purchases 58,938 Shares of Stock
09:52am, Wednesday, 11'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chirag K. Patel bought 58,938 shares of Amneal Pharmaceuticals stock in a transaction dated Wednesday, March 4th. The shares were bought at an average cost o
Analysts Expect Amneal Pharmaceuticals Inc (NYSE:AMRX) Will Post Quarterly Sales of $435.77 Million
05:04am, Tuesday, 10'th Mar 2020
Brokerages predict that Amneal Pharmaceuticals Inc (NYSE:AMRX) will post $435.77 million in sales for the current quarter, according to Zacks. Five analysts have provided estimates for Amneal Pharmace
Rhumbline Advisers Acquires 16,872 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
09:38am, Sunday, 08'th Mar 2020
Rhumbline Advisers lifted its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 13.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 147,019 shares of the company’
New York State Common Retirement Fund Grows Stock Holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX)
08:08am, Sunday, 08'th Mar 2020
New York State Common Retirement Fund grew its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 24.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and E
Joseph Todisco of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Just Spent US$145k On Shares
12:17pm, Saturday, 07'th Mar 2020
Investors who take an interest in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) should definitely note that insider Joseph...
Amneal Pharmaceuticals (NYSE:AMRX) Upgraded by Zacks Investment Research to Hold
08:54am, Saturday, 07'th Mar 2020
Zacks Investment Research upgraded shares of Amneal Pharmaceuticals (NYSE:AMRX) from a strong sell rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According
Amneal Pharmaceuticals (NYSE:AMRX) Trading 7.1% Higher Following Insider Buying Activity
06:22am, Friday, 06'th Mar 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX)’s stock price traded up 7.1% on Wednesday after an insider bought additional shares in the company. The stock traded as high as $4.17 and last traded at $4.09,
